1klm: Difference between revisions

From Proteopedia
Jump to navigationJump to search
← Older editNewer edit →
OCA (talk | contribs)
Bots, Bureaucrats, journal, Administrators
3,332,843 edits
No edit summary
OCA (talk | contribs)
Bots, Bureaucrats, journal, Administrators
3,332,843 edits
No edit summary
Line 1: Line 1:
[[Image:1klm.gif|left|200px]]
{{Seed}}
[[Image:1klm.png|left|200px]]


<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1klm|  PDB=1klm  |  SCENE=  }}  
{{STRUCTURE_1klm|  PDB=1klm  |  SCENE=  }}  


'''HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH BHAP U-90152'''
===HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH BHAP U-90152===




==Overview==
<!--  
The viral reverse transcriptase (RT) provides an attractive target in the search for anti-HIV therapies. The nonnucleoside inhibitors (NNIs) are a diverse set of compounds (usually HIV-1 specific) that function by distorting the polymerase active site upon binding in a nearby pocket. Despite being potent and of generally low toxicity, their clinical use has been limited by rapid selection for resistant viral populations. The 2.65-A resolution structure of the complex between HIV-1 RT and the bis(heteroaryl)piperazine (BHAP) NNI, 1-(5-methanesulfonamido-1H-indol-2-yl-carbonyl)-4- [3-(1-methyl-ethylamino) pyridinyl] piperazine (U-90152), reveals the inhibitor conformation and bound water molecules. The bulky U-90152 molecule occupies the same pocket as other NNIs, but the complex is stabilized quite differently, in particular by hydrogen bonding to the main chain of Lys-103 and extensive hydrophobic contacts with Pro-236. These interactions rationalize observed resistance mutations, notably Pro-236-Leu, which occurs characteristically for BHAPs. When bound, part of U-90152 protrudes into the solvent creating a channel between Pro-236 and the polypeptide segments 225-226 and 105-106, giving the first clear evidence of the entry mode for NNIs. The structure allows prediction of binding modes for related inhibitors [(altrylamino)piperidine-BHAPs] and suggests changes to U-90152, such as the addition of a 6 amino group to the pyridine ring, which may make binding more resilient to mutations in the RT. The observation of novel hydrogen bonding to the protein main chain may provide lessons for the improvement of quite different inhibitors.
The line below this paragraph, {{ABSTRACT_PUBMED_9108091}}, adds the Publication Abstract to the page
(as it appears on PubMed at http://www.pubmed.gov), where 9108091 is the PubMed ID number.
-->
{{ABSTRACT_PUBMED_9108091}}


==About this Structure==
==About this Structure==
Line 35: Line 39:
[[Category: Nucleotidyltransferase]]
[[Category: Nucleotidyltransferase]]
[[Category: Rna-directed dna polymerase]]
[[Category: Rna-directed dna polymerase]]
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri May 2 22:53:14 2008''
 
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Jul 2 10:31:10 2008''

Revision as of 07:31, 2 July 2008

File:1klm.png

Template:STRUCTURE 1klm

HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH BHAP U-90152

Template:ABSTRACT PUBMED 9108091

About this Structure

1KLM is a Protein complex structure of sequences from Human immunodeficiency virus 1. Full crystallographic information is available from OCA.

Reference

Unique features in the structure of the complex between HIV-1 reverse transcriptase and the bis(heteroaryl)piperazine (BHAP) U-90152 explain resistance mutations for this nonnucleoside inhibitor., Esnouf RM, Ren J, Hopkins AL, Ross CK, Jones EY, Stammers DK, Stuart DI, Proc Natl Acad Sci U S A. 1997 Apr 15;94(8):3984-9. PMID:9108091

Page seeded by OCA on Wed Jul 2 10:31:10 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "https://proteopedia.org/index.php?title=1klm&oldid=621382"